Skip to content
TRENDING:
Donald Trump
Advertisement

Tom Howell Jr.

Tom Howell Jr.

Tom Howell Jr. covers politics and the White House for The Washington Times. He can be reached at thowell@washingtontimes.com.

Articles by Tom Howell Jr.

President Donald Trump responds to Democratic presidential candidate former Vice President Joe Biden during the first presidential debate Tuesday, Sept. 29, 2020, at Case Western University and Cleveland Clinic, in Cleveland, Ohio. (AP Photo/Morry Gash, Pool)

Trump-Biden trade barbs over Obamacare in opening of presidential debate

The 2020 presidential debate opened with fireworks over Obamacare, with President Trump ducking a question on a "comprehensive replacement" by pointing to half-measures and former Vice President Joseph R. Biden insisting he wants to expand the law instead of upending private insurance. Published September 29, 2020

President Donald Trump speaks about coronavirus testing during an event in the Rose Garden of the White House, Monday, Sept. 28, 2020, in Washington. (AP Photo/Evan Vucci)

White House details shipments of 150M rapid virus tests

The U.S. will ship 6.5 million rapid coronavirus tests to governors this week, the administration said Monday, dubbing it a "game-changer" that will help states protect first responders and open schools safely as the federal government rolls out the 150 million easy-to-use tests it purchased from Abbott Laboratories during the GOP convention. Published September 28, 2020

President Donald Trump delivers remarks on healthcare at Charlotte Douglas International Airport, Thursday, Sept. 24, 2020, in Charlotte, N.C. (AP Photo/Evan Vucci)

Trump signs executive order preserving preexisting condition coverage

President Trump signed an executive order Thursday that says it is the "policy of the United States" that health insurers cannot deny coverage to people with preexisting conditions, even if the Supreme Court strikes down the same protections in Obamacare. Published September 24, 2020

This September 2020 photo provided by Johnson & Johnson shows a single-dose COVID-19 vaccine being developed by the company. Johnson & Johnson is beginning a huge final study to try to prove if the single-dose vaccine can protect against the coronavirus. (Cheryl Gerber/Courtesy of Johnson & Johnson via AP)

Johnson & Johnson launches massive human trial of COVID-19 vaccine

Pharmaceutical giant Johnson & Johnson started a massive human trial of its coronavirus vaccine Wednesday, lining up another option as federal officials told Congress they will resist political pressure ahead of an unprecedented push to inoculate the country. Published September 23, 2020

Vice President Mike Pence's National Security Adviser Keith Kellogg speaks during a press briefing in the James Brady Press Briefing Room at the White House in Washington, Tuesday, Sept. 22, 2020. McEnany said "I fired her" referring to Pence's former homeland security advisor Olivia Troye, who has recently criticized President Donald Trump's handling of the pandemic. (AP Photo/Andrew Harnik)

Keith Kellogg fired Olivia Troye when work performance dropped

The national security adviser to Vice President Mike Pence scolded Olivia Troye -- the former aide painting a damning portrait of President Trump's coronavirus response -- in unusually blunt terms Tuesday, saying she made up stories from the task force room and couldn't do her own job. Published September 22, 2020

College students seem to be caught in fears about coronavirus transmission, but aren't succumbing to the disease, which hits older adults the hardest. Public health officials say it's only a matter of time before off-campus activities will spill into the community and reverse gains made against the disease. (Associated Press)

Public health officials fear college students will spread coronavirus

Few college students are landing in the hospital from the coronavirus but they remain the crosshairs of public officials who fear their parties and lax adherence to quarantine rules are bound to fuel community spread off-campus, hurting the vulnerable. Published September 22, 2020

Democratic presidential candidate former Vice President Joe Biden speaks at Wisconsin Aluminum Foundry in Manitowoc, Wis., Monday, Sept. 21, 2020. (AP Photo/Carolyn Kaster)

Biden: Don’t get ‘numb’ to COVID-19 death toll of 200K

Americans cannot become "numb" to COVID-19 as the death count reaches 200,000, Joseph R. Biden said Monday, saying complacency will cost more lives and using a speech in Wisconsin to fault President Trump for the world-leading toll of fatal cases. Published September 21, 2020

The sun rises behind the Washington Monument on the last day of summer in Washington, Monday, Sept. 21, 2020. (AP Photo/J. David Ake) ** FILE **

Nation memorializes COVID-19 deaths as somber milestone nears — 200K

Thousands of flags will adorn the National Mall on Monday to memorialize 200,000 deaths from the coronavirus, one of many memorials as the U.S. closes in on a once-unfathomable milestone in its battle with a virus unknown to humans one year ago. Published September 21, 2020

President Donald Trump speaks at a campaign rally, Saturday, Sept. 19, 2020 at the Fayetteville Regional Airport in Fayetteville, N.C. (AP Photo/Chris Carlson)

Trump on Supreme Court pick: It will be a woman

President Trump said Saturday it cannot be "more clear" that he's empowered to fill the vacant Supreme Court seat left by the death of Justice Ruth Bader Ginsburg and that his pick will be a woman, beaming as a North Carolina crowd chanted, "Fill that seat!" Published September 19, 2020

In this Monday, July 27, 2020, file photo, a nurse prepares a shot as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway in Binghamton, N.Y. On Sept. 18, President Trump said he expects some 100 million doses of a coronavirus vaccine could be distributed by the year's end. (AP Photo/Hans Pennink) **FILE**

Trump: U.S. on track to deliver 100M vaccine doses by end of 2020

The U.S. is on track to manufacture 100 million doses of coronavirus vaccine by the end of this year and have enough for "every American" by April, President Trump said Friday, putting down a marker for delivery as drugmakers race to determine whether candidates in late-stage trials are safe and effective. Published September 18, 2020

In this Oct. 8, 2013, file photo, a sign marks the entrance to the federal Centers for Disease Control and Prevention (CDC) in Atlanta. (AP Photo/David Goldman, File) **FILE**

CDC reverses controversial guidance on asymptomatic testing

The Trump administration is fighting itself alongside the coronavirus, offering conflicting messages on testing, masks and vaccine timelines as a defector from the White House task force says President Trump is too self-centered to lead an effective response. Published September 18, 2020

In this Monday, July 27, 2020, file photo, a nurse prepares a shot as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway in Binghamton, N.Y. On Sept. 18, President Trump said he expects some 100 million doses of a coronavirus vaccine could be distributed by the year's end. (AP Photo/Hans Pennink) **FILE**

Moderna targets November to know coronavirus vaccine’s effectiveness

Drugmaker Moderna will probably know by November whether its vaccine is effective against the coronavirus, describing its human trial in detail Thursday to gain public trust while the White House defended its speedy timeline for inoculating the country. Published September 17, 2020